Required fields are marked with *

Verification code

SARS-CoV

CAS No. Product Name Inquiry
PLpro-IN-2
PLpro-IN-3
PLP-Snyder530
PLP Snyder530 is a potent papain-like protease (PLpro) inhibitor with an IC50 value of 6.4 μM. PLP_Snyder530 induces conformational changes in SARS-COV-2 papain-like protease, inhibiting SARS-CoV-2 replication. PLP Snyder530 can be used for SARS-CoV-2 research.
PROTAC SARS-CoV-2 Mpro degrader-3
RdRP-IN-7
Remdesivir impurity 9-d4
Remdesivir-d4
Remdesivir-d4 is deuterium labeled Remdesivir. Remdesivir (GS-5734), a nucleoside analogue with effective antiviral activity, has EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro.
Remdesivir-d5
Remdesivir-D5 (GS-5734-D5) is a deuterium labeled Remdesivir. Remdesivir (GS-5734) is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in vitro.
Remdesivir-impurity-9-d4
Remdesivir impurity 9-d4 is deuterium labeled Remdesivir. Remdesivir (GS-5734), a nucleoside analogue with effective antiviral activity, has EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro.
RH12
Ribavirin-15N, d2
Ritonavir-13C,d3
Ritonavir-13C-d3
Ritonavir-13C,d3 (ABT 538-13C,d3) is the 13C- and deuterium labeled Ritonavir. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.
Ritonavir-d6
Ritonavir-d6 (ABT 538-d6) is the deuterium labeled Ritonavir. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.
Ritonavir-d8
SARS-CoV-2 3CLpro-IN-19
SARS-CoV-2 3CLpro-IN-21
SARS-CoV-2 3CLpro-IN-22
SARS-CoV-2 3CLpro-IN-23
SARS-CoV-2 Mpro-IN-13

※ Please kindly note that our services are for research use only.

Copyright © 2024 BOC Sciences. All rights reserved.